Patient Registry Thalidomide Embryopathy
Recruiting
- Conditions
- Q86.80
- Registration Number
- DRKS00031883
- Lead Sponsor
- Contergansprechstunde, Schön Klinik Hamburg SE & Co. KG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
People with Thalidomide Embryopathy
Exclusion Criteria
People without Thalidomide Embryopathy
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Setting up a Patient Registry with informations according to ICF-Standard<br>(i)Bodyfunction<br>(ii)Bodystructures<br>(iii)Activities of dayli life and participation<br>(iv)Environmental factors
- Secondary Outcome Measures
Name Time Method Derivation of research hypothesis<br>Derivation of recommendations for provision of medical care and social support